s6y
Company name or ticker
Search
Dianthus Therapeutics, Inc. /DE/
S-3MEF
A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-3
Filed
Tuesday, March 10, 2026
Accession number
0001193125-26-100860
Documents
S-3MEF
S-3MEF
EX-23.1
EX-23.1
EX-FILING FEES
EX-FILING FEES
On sec.gov
Filing index
All files
Complete submission text
SGML header